KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Equity Ratio: 2014-2025

Historic Equity Ratio for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to 0.69.

  • Aurinia Pharmaceuticals' Equity Ratio fell 1.83% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year decrease of 1.83%. This contributed to the annual value of 0.69 for FY2024, which is 0.59% down from last year.
  • Aurinia Pharmaceuticals' Equity Ratio amounted to 0.69 in Q3 2025, which was up 3.92% from 0.67 recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Equity Ratio's 5-year high stood at 0.89 during Q1 2021, with a 5-year trough of 0.67 in Q2 2025.
  • Moreover, its 3-year median value for Equity Ratio was 0.70 (2024), whereas its average is 0.71.
  • In the last 5 years, Aurinia Pharmaceuticals' Equity Ratio climbed by 6.25% in 2021 and then declined by 19.91% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.88 in 2021, then decreased by 2.34% to 0.86 in 2022, then dropped by 19.91% to 0.69 in 2023, then declined by 0.59% to 0.69 in 2024, then dropped by 1.83% to 0.69 in 2025.
  • Its last three reported values are 0.69 in Q3 2025, 0.67 for Q2 2025, and 0.69 during Q1 2025.